Rony Dahan, PhD

ICRF is currently supporting several projects in this area of cancer treatment. Meet one of the currently funded researchers below:

Dr. Dahan, an Assistant Professor in the Department of Immunology at the Weizmann Institute of Science, studies the mechanisms that control the activity of both natural and therapeutic antibodies. His lab is currently exploring the molecular interactions that mediate the anti-cancer immune response, in order to uncover the principles which will allow them to design more effective immunotherapy drugs, with less side-effects, for a variety of cancer types.

View Grant Recipient Profile